Previous 10 | Next 10 |
EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesd...
Summary Robust financial results from the previous quarter, driven by end-market demand and e-commerce sales channels. Fundamental momentum gathering with profitability a standout last period from strong sales growth. Technicals equally supportive of further upside capture. Rate...
Class A shares of micro-cap pet medication and wellness company PetIQ ( NASDAQ: PETQ ) jumped 32.2% to $9.46 in Thursday morning trading, after it reported a Q3 results beat and raised its FY 2022 adj. EBITDA guidance. It is worth noting that PETQ stock had already been ...
PetIQ, Inc. (PETQ) Q3 2022 Earnings Conference Call November 9, 2022 16:30 ET Company Participants Katie Turner - Investor Relations Cord Christensen - Chairman & Chief Executive Officer Zvi Glasman - Chief Financial Officer Michael Smith - President &...
PetIQ press release ( NASDAQ: PETQ ): Q3 Non-GAAP EPS of $0.15 beats by $0.09 . Revenue of $209.7M (-0.4% Y/Y) beats by $5.37M . For the full year 2022 the Company expects: -Net sales of $920 million to $940 million vs $926.62M Consensus. Adjusted EBI...
Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of $64.5 Million Raises 2022 Annual Adjusted EBITDA Outlook EAGLE, ...
EAGLE, Idaho, Oct. 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the third quarter ended September 30, 2022, on Wednesday, No...
Summary Times have been tough for shareholders of Petco Health and Wellness Company, with shares plummeting and profits down. But management has high hopes for the rest of the current fiscal year, even though guidance is lower than previously forecasted. Given how cheap shares...
PetIQ ( NASDAQ: PETQ ) to repurchase up to $30M in aggregate of the company's outstanding shares of common stock. “We have confidence in PetIQ’s business model, financial strength, and future growth opportunities which we believe are undervalued in the Compan...
EAGLE, Idaho, Sept. 06, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that as part of the Company's long-term strategy to maximize stockholder value, its Board of Dir...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 19:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
EAGLE, Idaho, June 05, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today announced that members of its executive management team will participate in the Oppenheimer 24th Annual ...